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Background 
Approximately 100,000 people in the United States are affected by Sickle Cell Disease (SCD).  
Sickle Cell Disease represents the second highest readmitting diagnosis at Houston Methodist 
Hospital. The purpose of this study is to determine the impact of implementing care coordination 
interventions to reduce hospital readmissions of patients with SCD. 
 
PICOT 
In adult patients with SCD in the acute care hospital setting, how does care coordination 
intervention compared to no care coordination intervention affect the readmission rate for 
patients with SCD over a 3 – 6-month period? 
 
Body of Evidence 
Eleven studies were critical appraised and included in the body of evidence: One Randomized 
Control Trial, seven Cohort Studies, and three Quality Improvement Projects.  Four evidence-
based interventions were found to reduce readmissions for SCD patients. 
 
Implementation 
Two interventions were implemented:  Disease-specific discharge education and scheduling 
post-discharge follow-up appointments prior to discharge.  These interventions were conducted 
by bedside nurses, case managers, and SCD champions over six-months. 
 
Outcomes/Evaluation 
The 30-day readmission rate for SCD was reduced by 22%.  There was also a 0.9-day reduction 
in length of stay and a 17% reduction in Emergency, Observation, and Inpatient encounters. 
 
Impact 
This project found that implementing evidence-based care coordination interventions can reduce 







Effective care coordination is a key aspect to mitigation of hospital readmissions.  Establishing 
processes to incorporate these strategies into the daily work of care coordinators may serve as the 




Chapter One: Development of the Leadership Question and Problem Identification 
Introduction 
Approximately 100,000 people in the United States (U.S.) are affected by sickle cell 
disease (SCD) (Bulgin et al., 2018). One out of every 365 African Americans and one out of 
every 16,300 Hispanic-Americans are diagnosed with the disease at birth (Centers for Disease 
Control and Prevention, 2019). The state of Texas is the third leading state in SCD incidence 
with one in every 500 African Americans and one in every 3,600 Hispanic-Americans affected 
(Yates, 2014). This accounts for 23% of the total population of patients with SCD in the US 
(Sickle Cell Association of Houston, 2018). Patients with SCD are hospitalized approximately 
eight times per year (Sickle Cell Association of Houston, 2018). The average cost per admission 
is $27,700 and the average cost of healthcare expenditures over the lifespan is $7.7 million. 
(Sickle Cell Association of Houston).  Re-hospitalization rates for SCD range from 30-47% and 
22.1% for 30 days and 14 days, respectively (Leschke et al., 2011).  
External Evidence 
People living with SCD face significant morbidity and early mortality (Wilkie et al., 
2010). From 1975-2005, the mean age of death for people with SCD was 33.4 years for males 
and 36.6 years for females. The mortality rate for adults increased by one percent each year 
during the same period (Lanzkron & Haywood, 2015). Following the FDA approval of 
hydroxyurea, the life expectancy for patients with homozygous SCD increased to 42 years for 
males and 48 years for females (Okam et al., 2014). This demonstrates that patients with SCD 




2018; Statista, 2019; Tewari et al., 2015). Approximately 10% of children with SCD will have a 
symptomatic stroke, which can cause learning problems and lifelong disabilities (American 
Society of Hematology, 2016). In some African countries, nearly all babies born with SCD die in 
early childhood (Wilkes et al., 2010).   
Sickle cell disease is characterized by chronic hemolytic anemia, increased susceptibility 
to infections, end organ damage, and intermittent episodes of vascular occlusion that result in 
acute and chronic pain (Centers for Disease Control and Prevention, 2019).  Inadequate pain 
management decreases quality of life and patient satisfaction and increases hospital length of 
stay and 30-day readmission rates (Ballas & Lusardi, 2005; Ezenwa et al., 2016; Treadwell et al., 
2016). Brodsky et al. (2017) ascertained that the cost of care in the U.S. exceeded $1.1 billion, 
predominantly from hospitalizations,.  Cline et al. (2018) found that the 30-day readmission rate 
for SCD approached 32% in 2010. Treadwell et al. (2016) discovered that in patients with SCD, 
complications and health care costs significantly increased after age 16.   
The transition from childhood to adulthood is a high-risk period for youth with SCD due 
to the complexities of a disease where multiple comorbidities develop in childhood and progress 
in adulthood (Blinder et al., 2013; Treadwell, 2018; Dickerson et al., 2012). Disease 
complications may be exacerbated during this period secondary to poor continuity and resulting 
in increased morbidity and mortality after age 18 years. In a large cohort study in Texas, of 940 
children who were followed from birth, seven deaths occurred between age 18 and 20 (Quinn et 
al., 2010). The transition period is also a contributor to increased stress and frustration for 
patients with SCD and providers (Stollon et al., 2015). 
Many patients with SCD also struggle with psychosocial and economic barriers. These 




(HRQL) (Panepinto et al., 2007), and lack resources to adequately maintain self-care (Jenerette 
et al., 2015). Patients with SCD also are typically challenged by numerous social determinants of 
health (SDOH) and may suffer from a concomitant psychiatric illness (Adam et al., 2017). They 
frequently have poor social support and lack trust with a healthcare provider, thus contributing to 
strained relationships (Weisberg et al., 2013).  Healthcare disparities greatly impact patients with 
SCD as barriers to access to care, inadequate training and treatment, and lack of funding for 
research to improve treatment continue to exist (American Society of Hematology, 2016). Lack 
of education, negative provider attitudes towards patients with SCD, and poor provider 
knowledge about SCD worsens pain management (Haywood et al., 2009). 
Internal Evidence 
At Houston Methodist Hospital (HMH), SCD is the one of the highest readmitting 
diagnoses with >46% of patients readmitted within 30-days of discharge (Vizient, 2018). It is 
estimated that 20 – 30% of these readmissions were preventable. Between June 2017 and 
December 2018, there were 391 inpatient encounters for SCD, where 13 patients accounted for 
30% of the encounters and 322 emergency room (ED) encounters for SCD where eight patients 
accounted for 60% of the visits (Epic ED Universe, 2018). The average length of stay (ALOS) 
for patients with SCD was seven days compared to an expected length of stay (LOS) of four days 
(Vizient, 2018).  The cost of care per visit averaged around $20,000. The Hospital Consumer 
Assessment of Healthcare Providers and Systems (HCAHPS) scores for patients with SCD on 
communication with nurses, pain management, care transitions, and discharge information 
measures were in the 25th percentile (Hospital Consumer Assessment of Healthcare Providers 




The average age of patients with SCD that presented to Houston Methodist Hospital 
between June 2017 and December 2018 was 26 years. Forty percent of these patients had 
moderate to high severity of illness (SOI) and risk or mortality (ROM) based on clinical 
documentation (Claro Healthcare, 2018). Seventy-five percent had a high probably of 
readmission secondary to eight or more SDOH.  Some of these included problems related to: 
Education and literacy, employment or unemployment, physical or social environment, housing, 
and certain economic or psychosocial circumstances. The combination of physiological and 
psychological issues predisposes patients with SCD to frequent and prolonged hospitalizations 
and high risk for early death. These factors influence the probability of patients falling through 
the cracks and landing in hospital emergency rooms where approximately 40% of visits result in 
inpatient admission (Lanzkron & Haywood, 2015).   
Development of the Clinical/Leadership Question and Problem 
The number of risk factors and SDOH were of great concern to the executive team. 
Combined with high readmission rates and length of stay for patients with SCD, the readmission 
reduction task force at HMH agreed that this issue required immediate action. To identify 
literature to address these concerns, the following PICOT question was asked: In adult patients 
with SCD in the acute care hospital setting, how does care coordination intervention compared 
to no care coordination intervention affect the readmission rate for patients with SCD over a 3- 






Chapter 2: Evidence Synthesis and Models 
Systematic Search for Evidence Process and Results 
 A systematic search of three electronic databases was conducted to identify studies to 
assist with decision-making. The Cumulative Index of Nursing and Allied Health Literature 
([CINAHL]; Appendix A), PubMed (Appendix B), and the Cochrane Database of Systematic 
Reviews ([CDSR]; Appendix C)) were the databases searched. A foreground question was 
formatted to drive the search, and keywords, inclusion criteria, use of subject headings or 
controlled vocabulary, and combining and limiting searches were all strategies used to find the 
best evidence to help answer the PICOT question.   
 The keywords search included the following terms: anemia, sickle cell, disease, sickle 
cell, SCD, sickle, care coordination, case manage*, social work, coordination of care, continuity 
of care, readmi*, 30-day readmi*, and readmission (see Appendices A, B, and C). To ensure 
consistency with the systematic search, the same search terms and order of search was conducted 
across all databases. Additionally, advanced searching was conducted to support finding the best 
relevant evidence and, for databases with controlled vocabulary or indexing functionality, those 
terms were also explored. Furthermore, other types of applications were assessed some of which 
included a search for multiple types of clinical evidence, clinical practice guidelines, article 
synopsis, and bibliographic databases. 
 Inclusion criteria and limits were used to narrow the results. The criteria comprised the 
following: human, English language, abstract available, peer reviewed, and inpatients. 
Randomized control trials (RCTs) and meta-analyses were included in the limit settings initially 
as a means of identifying the strongest evidence to support clinical decision-making. 




answer the foreground question. Boolean connectors and truncation were utilized to streamline 
the search.   
 Subject headings were incorporated into the search strategy to identify pertinent articles. 
Within CINAHL, the “explode” and major concept features were utilized to ensure all the 
specific terms were included under the general headings. Combined with the Boolean feature, 
variations of sickle cell anemia or sickle cell disease and case manage, social work, care 
coordination, and continuity of care produced a range of three to 62 hits. Adding a truncation of 
readmission resulted in a range of one to three hits.  After further review, the total yield from 
CINAHL was three articles.  
Within the PubMed database, the Medical Subject Heading (MeSH) feature was utilized 
broaden the search to avoid having to consider every synonym (Melnyk & Fineout-Overholt, 
2015).  The explode subject heading was utilized to narrow the search. These strategies, 
combined with the Boolean connector feature, produced a range of eight to 197 abstracts or 
articles. Combining a truncation of readmission produced a range of zero to nine hits.  After 
further review, the total yield from PubMed was two articles.  Within CDSR, the MeSH feature 
was also utilized.  Additional use of the Boolean connector produced one hit. Combining a 
truncation of readmission produced zero hits. Total yield from CDSR was zero articles. 
Five articles provided relevant information to help answer the PICOT question. To 
identify additional studies, the find similar results feature in CINAHL and similar articles 
feature in PubMed was also used.  This led to an additional three articles. Google was searched 
for other articles of interest and grey literature, and the ancestry method, along with hand 




yielding a total of 11 articles retained for critical appraisal:  One RCT, seven cohort studies, and 
three quality improvement projects (QIPs).   
Critical Appraisal 
 A general appraisal overview (GAO) was conducted for each study to determine the 
purpose or aim, design, and sampling specifics. A rapid critical appraisal (RCA) was conducted 
for each study to appraise the evidence and to determine whether the literature identified in the 
search was relevant, valid, reliable, and applicable to the clinical question (Melnyk et al., 2010).  
The RCA helps to distinguish the best evidence from unreliable evidence and unbiased evidence 
from biased evidence (Melynk & Fineout-Overholt, 2015). In appraising the literature, articles 
were evaluated considering the level of evidence and the degree to which each answered the 
clinical question (Melnyk et al., 2010).   
When conducting the RCA, the framework was reviewed to assess the clinical question, 
variables, and study design to determine generalizability. Although systematic reviews and RCTs 
represent higher levels of evidence, only one article in the upper echelon of the rating hierarchy 
was found. Validity, reliability, and applicability were high for the RCT and moderate for the 
cohort studies for the quality improvement studies.  Several of the articles included studies or 
projects implemented in the pediatric or combination of pediatric and adult inpatient and/or 
outpatient settings.  Considering the onset and chronicity of SCD and the importance of care 
coordination across the continuum, these articles were retained as they contained information 
relevant to the clinical question. Also, many of the articles conducted studies longer than the 3–
6-month timeframe referenced in the PICOT question. These articles were also retained. Thus, 






  An evaluation table was created to organize, compare, and describe agreement amongst 
the findings of the 11 keeper studies (See Appendix D).  Levels of evidence ranged from level II, 
well-designed RCTs, to Level VI, QIPs. The studies were a broad collection published between 
2012 and 2018. Evaluation of the studies found similarities with types of study and interventions. 
Statistically significant readmission reduction was noted in many of the studies.  Differences 
include age, setting, process measures, and data analysis.  Despite the differences, the evidence 
supported implementing care coordination interventions to reduce readmissions. 
An assessment of the principles of ethics was completed.  The review of the principles of 
ethics assisted with providing confidence that the proposed interventions could be implemented 
in a manner that protects patient confidentiality and ensures patient safety.  Five principles of 
ethics were considered in the review: beneficence, non-maleficence, autonomy, justice, and 
fidelity. No ethical issues were noted (see Appendix E). The Houston Methodist Research 
Institute (HMRI) also conducted a review of the project.  The HMRI determined there was no 
need for to obtain Institutional Review Board (IRB) approval (see Appendix F).  The 
organization supported proceeding with project implementation.   
Synthesis 
 Four synthesis tables were developed to clarify similarities and differences across studies: 
Levels and types of evidence; interventions; outcomes; and studies with similar findings (See 
Appendices G, H, I, and J). Appendix G highlighted that most of the evidence was from cohort 
studies, with quality improvement projects most common. Appendix H revealed common 
interventions were: Disease-specific discharge education, care planning during the inpatient 




discharge follow-up calls, home visits, and follow-up / post-discharge care in an outpatient 
infusion center. Appendix I demonstrated that discharge education, scheduling follow-up 
appointments prior to hospital discharge, and outpatient follow-up (i.e., in a sickle cell infusion 
center) interventions were the most effective in reducing 30-day hospital readmissions, the 
primary outcome of interest. Furthermore, scheduling of post-discharge follow-up appointments 
prior to discharge appeared to be the most effective intervention with the broadest impact. 
Finally, Appendix J showed that care coordination strategies, specifically, the inpatient, disease-
specific, discharge planning education and scheduling follow-up appointments prior to patient 
discharge have significant impact on reducing 30-day hospital readmission rates and mild impact 
on reducing hospital length of stay. 
Recommendations 
 Based on the body of evidence, the recommendation is implementation of disease-
specific discharge teaching on patient self-management and arrangement of post-discharge 
follow-up appointments with a Primary Care Provider (PCP) or Hematologist prior to patient 
discharge.  Additionally, evidence suggests that conducting post-discharge calls and home visits, 
in combination with discharge education and scheduling post-discharge follow-up appointments 
prior to hospital discharge, may further reduce hospital readmissions. The expected outcome is a 
conservative 20% reduction in 30-day hospital readmissions for patients with SCD.   
EBP Model 
The EBP Model used to assess care coordination interventions and the impact on 30-day 
hospital readmissions of patient with SCD is The Johns Hopkins Nursing Evidence-based 




on guiding nurses and ancillary staff in translating the best evidence into practice. The goal of 
this model is to transform the culture of nursing to an evidence-based focus in a way that is 
simple, functional, and applicable. The model is a mentored linear process that begins with a 
clinical inquiry question and initiates a Practice Question, Evidence, and Translation (PET 
process) (Dang & Dearholt, 2017).  The PET process provides a systematic approach for the 
inter-professional team to refine the question, seek out the best evidence, and translate evidence 
into practice.  
Change Model 
The ADKAR change model was chosen to support change management throughout 
project implementation.  The ADKAR change management model is a tool for planning change 
management activities.  The ADKAR methodology outlines five milestones in successful 
change:  Awareness, desire, knowledge, ability, and reinforcement (Prosci, 2018).  Awareness 
encompasses explaining the rationale for the change.  It creates the space to explain the why and 
allows for open communication and shared understanding.  Desire empowers and engages 
individuals through regular communication and collaboration.  Knowledge helps with 
identification of training needs including social learning.  This allows for reflection and sharing 
of experiences and ensures the necessary structure and tools are in place to implement new ideas. 
Ability focuses on assessment of how to accomplish tasks.  It also provides a safe space for 
inquiry of participant’s vulnerabilities and fears, barrier identification, and prioritization of tasks.  





 Leadership is an important aspect of actualizing the DNP role. Transformational 
leadership is a leadership approach that causes a change in individuals and social systems with a 
potential result that followers will become the leaders (Kendrick, 2011). Transformational 
leadership involves four factors: idealized influence, inspirational motivation, intellectual 
stimulation, and individual consideration (see Figure 1). Individually, these factors can provide 
forward movement, and cumulatively deliver performance that far exceeds previous norms 
(Kendrick, 2011).   
 The transformation leadership model was instrumental throughout implementation of the 
project.  It served to enhance the motivation, morale, commitment, and performance of the team.   
The team established a shared vision in the early stage of project implementation including 
setting ground rules and individual and team expectations.  Expectations encompassed elements 
of transformational leadership including:  Leading by example and role-modeling expected 
behaviors; encouraging and rewarding creativity and innovation (thinking outside of the box); 
demonstration of grace and tolerance; and exhibiting compassion and support. 






Chapter 3:  Project Design and Methodology 
Setting and Population 
The setting for conducting the interventions took place at the flagship hospital of Houston 
Methodist. Houston Methodist Hospital is a not-for-profit, faith-based, 907-bed hospital located 
in the Texas Medical Center that provides highly specialized health services to the community 
and the world (Houston Methodist, 2019). The population of focus was adult patients (>/=18 
years of age) diagnosed with SCD admitted as inpatient to HMH during the timeframe of August 
2019 – January 2020. Ninety-nine percent of this population was African American with the 
average age being 26 years old (Epic ED Universe, 2018; Vizient, 2018). The number of patients 
admitted with SCD was fifty-seven patients. Seventy percent of the patients were </= 29 years of 
age. Approximately 60% of those </= 29 years were between the ages of 21-29 years old.   
Approximately 90% of these patients were </= 39 years. 
Table 1  
Patient Demographics 
Age Number of patients 
18 – 20 6 
21 – 29 34 
30 – 39 11 
40 – 49 4 
50 – 59 2 
>60 0 
 
 Seventy-five percent of these patients had a primary payer source of Managed Medicaid 
(Epic ED Universe, 2018). Seventy-five percent of the patients were considered high risk for 




illness and risk for mortality index (Claro Health, 2018). Seventy-two percent of the population 
completed high school, yet only 5% of the population had college degrees.   
Patients that presented to HMH’s Emergency Department (ED) for care were registered 
by the admissions clerk and triaged by an ED nurse. At triage, an ED Provider screened patients 
and initiated a treatment plan. Patients deemed appropriate for discharge from the ED received 
discharge instructions on an After-Visit Summary (AVS), which included recommendations for 
follow-up and prescriptions. If the ED Provider determined that admission was necessary, she/he 
contacted a Hospitalist to admit the patient. The Hospitalist entered the admission orders and 
nursing and the interdisciplinary team (IDT) initiated the plan of care.   
An EPIC report was created and distributed daily. This report included any patient newly 
admitted with a primary diagnosis of SCD. The report was distributed to the Unit case manager 
or social worker for communication and collaboration with the attending physician and the 
interdisciplinary team. During interdisciplinary rounds, the team discussed the goals of care and 
anticipated discharge date with the patient. The primary nurse or case manager conducted patient 
education utilizing materials from the SCD Toolkit (see Appendix K) and documented education 
in the patient’s medical record. The case manager or social worker discussed an ideal date and 
time for post-discharge appointments and scheduled the appointments based on the patient’s 
preference.  When patients were medically ready for discharge, the Attending Physician entered 
the discharge order and instructions for post-discharge care on the AVS. The discharging nurse 
completed the treatment plan and provided the patient with the AVS and prescriptions.   
Timeline Including Gantt Chart 
A timeline for the EBP project was created to establish clear direction and priorities.  The 




along with specific time intervals.  A Gantt Chart was also completed.  The Gantt Chart served 
as a visual depiction of project tasks and milestones.  It was also used to improve 
communication, efficiency, and effectiveness.  The Gantt Chart allowed for greater specificity of 
the project scope and provided a better lens into past, present, and future project activity (See 
Appendix L).    
Logic Model 
A Logic Model was completed to assist with project planning and implementation.  The 
Logic model provide a visual illustration of project resources, activities, and expected outcomes.  
Inputs included human and organizational resources and supply needs.  Outputs included 
educational and training activities to support project implementation and sustainability.  Short-
term, midterm and long-term goals were established, and an assessment of assumptions and 
external factors was completed (see Appendix M).   
Implementation of evidence-based practice may be fraught with barriers and challenges 
that impede or hinder progress and outcomes.  Lack of resources such as IT support, time 
restrictions, heavy workload, and organizational constraints are also potential barriers to EBP 
implementation (Fischer et al., 2016).  The success of EBP implementation hinges upon several 
factors.  Incorporating interventions into the normal workflow of staff and simplifying processes 
will help mitigate barriers and challenges. To minimize or reduce barriers, a barriers action plan 
was implemented (see Appendix N).  
Utilization of the EBP Model 
The JHNEBP served as the framework to provide the interdisciplinary team with a visual 




improvement. The JHNEBP framework supported the interprofessional team throughout the 
steps of the EPB process to ensure: (a) the process was structured and systematic; (b) appropriate 
identification and implementation of EBP interventions that answered the clinical question; (c) 
adherence to the project timeline, goals, and objectives; (d) increased probability for successful 
patient outcomes and patient, physician, and staff engagement and satisfaction; (e) decreased risk 
of error; and (f) minimized opportunities for scrutiny or criticism. The EBP Model demonstrated 
the integration between the EBP Process and the JHNEBP model.  The multi-linear approach 
supported implementation of the interventions in a simple format and strengthened buy-in, 
sustainability, and success. It also yielded operational and practice improvements that led to 
additional inquiry and discovery (see Appendix O). 
Utilization of Change Model 
The ADKAR change model was utilized to support organizational change and project 
implementation. The initial focus was helping stakeholders and the project team understand the 
need for change. This included assessment of the size and scope of the change, completion of the 
OSRSIEP, and providing the structure and strategy for change. We then moved to development 
of our roadmap, and communication, training, and coaching plans. To reinforce change, we 
worked with key stakeholders to collect and analyze feedback, diagnose gaps, identify and 
manage resistance, and develop corrective action plans. Finally, we implemented reward and 
recognition activities to celebrate success and reinforce positive behavior (see Appendix P).  The 
ADKAR change model provided a strong framework for expectations and accountability.  
Stakeholder familiarity with the model made implementation easier and helped boost team 





Estimated expenses for this project were approximately $42,000.  This included costs for 
salaries, supplies, marketing/communication, training, and other expenses. The salary line item 
included cost of time for the Nurse Educators or Case Managers to conduct training sessions and 
for the nurses, Case Managers, Social Workers, and Community Health Workers to conduct the 
interventions. The supplies line item included costs for material needed to successfully 
implement the interventions. This included paper, ink, binders, and dividers. The 
marketing/communication line item included costs for hospital branded personal health records 
for distribution to each patient; and the other line item includes costs for CHW mileage 
reimbursement (see Appendix Q). 
The return on investment (ROI) was determined by assessing the reduction in 
unnecessary readmissions as cost avoidance. A 20% reduction in avoidable readmissions was 
anticipated.  The pre-intervention total number of readmissions was 95. The anticipated number 
of readmissions post-intervention was </=75. The anticipated return on investment expressed as 
cost avoidance was as follows:       
 
Pre-implementation readmissions cost $20,000 cost/readmission X 95  = $1.9M 
Post-implementation readmissions cost $20,000 cost/readmission X 75 = $1.5M 
$1.9M - $1.5M  =  $400K savings 
$400,000 - $42,000 implementation costs = $358,000 ROI. 




Data Collection and Analysis Plan 
Data management needs included information on compliance with process measures and 
the resulting impact on the outcomes measure. Process measures included:   
1. Percentage completion of at least one SCD-specific educational session divided by the 
total number of educational opportunities 
2. Percentage of post-discharge appointments scheduled prior to discharge divided by the 
total number SCD discharges.    
3. Percentage of weekly post-discharge phone calls divided by the total number of expected 
calls per patient.  
4. Percentage of post-discharge home visit completed divided by the total number of 
expected home visits. 
 These process measures were chosen as a means of assessing and tracking compliance 
with the four evidence-based interventions originally planned for implementation. SCD-specific 
discharge education and scheduling of post-discharge follow-up appointments were 
implemented, and process measure data was collected. Bi-weekly reports were supplied by the 
quality analytics team. Data were based on documentation in the electronic medical record. 
Indications that the project was progressing well included feedback from the project team and 
consistent documentation completion of interventions. 
The 30-day hospital readmission rate for patients with SCD was the outcome measure. 
This measure was chosen because it is a high-impact metric that reflects the quality of care and 
services provided. The Centers for Medicare and Medicaid Services’ (CMS) readmission data 
typically runs a few months in arrears; thus, concurrent data was tracked using the hospital’s 




our internal data with the CMS readmission methodology. Internal data only included 
readmission back to the Houston Methodist system and CMS data included readmission to any 
hospital.   
Readmission data included inpatient to inpatient admissions within 30 days of the index 
admission (discharged in inpatient status and readmitted in inpatient status) for any diagnosis. 
Patients returning to the hospital within 30 days of discharge in observation status were not be 
counted as a readmission. The data analysis plan included an analysis of historical data compared 
to post-implementation data. Discrete data was collected and aggregated and the 5 Whys was 





Chapter 4: Project Implementation, Outcomes, Impact, and Results 
Process Indicators/Milestones 
Process measure data components included interventions completed compared to the total 
number of opportunities. Data were measured and reported as a percentage. The threshold or 
minimum completion was set at 90%. Target and stretch goals were set at 95% and 100%, 
respectively.  
Project Results, Barriers, and Solutions 
 The original intent was implementation of four interventions over a three-month 
timeframe. A late fall, early winter implementation was planned as this timeframe correlated 
with higher readmissions for this population. The Senior Leadership Team expressed concerns 
about the timeline and requested initiating the project earlier. They recommended 
implementation in late summer or early fall in anticipation of the influenza season and to prevent 
high SCD readmissions historically seen during cooler months. There was also anecdotal 
information from providers that follow-up compliance for patients with SCD decreased during 
cooler temperatures further supporting the need to initiate the project sooner. The compromise 
was to implement two of the four evidence-based interventions over a six-month period. Thus, 
sickle cell disease-specific education and scheduling of post-discharge follow-up appointments 
prior to discharge were implemented between August 2019 through January 2020.  
 Implementation of post-discharge follow-up calls and Community Health Worker (CHW) 
home visits were planned for April 2020 – June 2020. Unfortunately, the COVID-19 pandemic 
halted implementation. The world, including the U.S. and the state of Texas, was severely 




Methodist Hospital closed approximately half of the units and shifted many medical patients to 
other hospitals in the system. This included patients with SCD. Additionally, several of the 
hospital staff were furloughed, some for several months during the height of the pandemic. This 
included case management and social work staff. Case managers and social workers that were 
not furloughed covered multiple units. They also shifted their workflow from in-person to 
telephonic coordination to avoid exposure, risk of spread, and retain vital PPE for roles required 
for patient facing.   
In-person office visits shifted to virtual visits making coordination of care for patients 
with SCD more challenging. Furthermore, visitation for post-acute care and other partners was 
prohibited; thus, in-person hand off to the SCAH could not happen. There was also trepidation 
regarding home visits from patients, family members, and the SCAH. To date, COVID-19 
continues to plague HMH. Implementation of the remaining two interventions continue to be on 
hold. Though unable to implement all four of the evidence-based interventions, implementation 
of SCD-specific discharge education and scheduling of post-discharge follow-up appointments 
together had a significant impact on the SCD 30-day hospital readmission rate.   
Data Collection and Analysis 
 Process measure compliance for SCD-specific educational sessions to patients was 100%. 
There were 178 encounters and documentation of SCD-specific education prior to patient 
discharge was present in the medical record of all encounters. Education was considered 
complete if documented in any of the following areas: (a) nursing documentation in-progress 
notes or flowsheets, (b) case manager or social worker documentation in-progress notes, or (c) 




Process measure compliance for scheduling of post-discharge follow-up appointments 
prior to discharge was 74%. Of the 178 encounters, documentation of post-discharge follow-up 
appointments prior to discharge was present in the medical record in 132 encounters. There was 
a total of 46 encounters where post-discharge follow-up appointments were not scheduled. Root 
cause analysis audits found the following causes: (a) 17 encounters of patient refusal or requests 
to self-schedule appointment, (b) 14 incomplete encounters, six unplanned discharges, (c) five 
encounters of staff omission, and (d) four late appointments (scheduled after patient discharge) 
(see Appendix R). An observation noted was case management and social work staff were more 
engaged and more likely to ensure documentation of confirmed appointments in the patient’s 
AVS when assisted or supported by the SCAH.   
Outcomes Measures, Analysis, and Financial Impact 
As a result of these interventions, total readmissions for this population were reduced by 
22%. The estimated cost of care per readmission was $20,000; thus, cost savings or avoidance 
totaled $620,000. Implementation costs were approximately $42,000; thus, the annualized ROI 
was $578,000.  This is $220,000 more savings than estimated (originated estimated savings were 
$358,000).  Also, average LOS was reduced by almost 1 day (7.7 down to 6.8) and Emergency 
Department and Observation visits decreased by 18.7% and 23.5%, respectively (see Appendix 
S).  This ROI does not include revenue gained from length of stay (LOS) reduction or increased 
capacity.  Increase capacity for patients needing acute care with higher paying diagnostic related 
groups (DRGs) was observed. Further analysis is needed to determine the overall ROI to include 
the following:  Reimbursement of other DRGs admitted minus that of SCD patients that would 
have been admitted; LOS savings; and improved ED and observation throughput. 




• What would the impact have been if all interventions were implemented? 
• What is the financial impact of the LOS reduction?   
• What was the financial impact (revenue obtained) from improving emergency room and 
hospital capacity? 
• What are the risks associated with longer LOS for patients with SCD?  Hospital acquired 
conditions or infections? Overdose of patient medications? Increased mortality? 
• What impact did or could this project have on overall patient, employee, and physician 
engagement and satisfaction?   
• How might this information change the perspective and practices of emergency 
department, general/internal medicine (Hospitalists), Hematologists, and other providers? 
• Did staffing, skill mix, or employee knowledge deficits impact completion of 
interventions (and thus process measures)? 
• How much of the outcomes were influenced by absence or presence of social support for 
this group of patients? 
• Would the outcomes be different if the interventions were administered by only RNs or 
Social Workers?  Would having both involved further impact the outcomes? 
• Would the outcomes be better if all education were done by the SCAH? 
• Would consistent demonstration and documentation of teach-back impact outcomes? 
• What would the impact be if we were not dealing with a global pandemic? 
• Would outcomes be different or better if SCD patients were centralized on specific units? 
• What percentage of patients attended follow-up appointments as scheduled?   
• Were better outcomes achieved for those that attended follow-up appointment as 





Smith et al. (2019) found that implementation of a case management model and CHW 
interventions reduced readmission rates by 17%, emergency department returns by 5%, SCD 
patient days by 53%, and SCD care costs by 47%. McWilliams et al. (2019) used random 
allocation to a Transition Services (TS) program that bridges inpatient, outpatient, and home 
settings.  The interventions provided patients virtual and in-person access to a dedicated 
multidisciplinary team for 30-days versus usual care of discharge instructions. They noted a 7% 
reduction in the readmission rate of those receiving transition services compared to those 
receiving usual care.  These studies provide additional insight into interventions that may 
improve care transitions across the continuum and subsequently assist hospitals and healthcare 
systems providing care to patients with SCD with achieving the Institute for Healthcare 





Chapter 5: Project Sustainability, Conclusions, and Recommendations 
Implications of Project Results 
 Organizationally, there is great opportunity to implement similar measures across the 
system as several of the Houston Methodist facilities provide care to patients with SCD.  
However, given the effect of COVID-19, one cannot predict the impact that this pandemic will 
have on the SCD population and the organization’s strategic plan. There has been discussion 
about centralizing care of patients with SCD on specific units at HMH and at specific Houston 
Methodist facilities; however, no decision has been made to date. Though policy revisions were 
not made, case management and social work departmental procedure and practice changes were 
implemented and standardized. Additionally, efforts are in progress to reengineer the current 
patient education processes and platforms. The intent is to boost patient awareness and 
understanding, enhance applicability and practicality of patient self-management and post-
discharge care, and ultimately, improve patient outcomes and satisfaction. These efforts are not 
specific to patients with SCD (though focus on this population may have served as a catalyst to 
such efforts) but to all patients.   
The implications of these results to the community have been noticeable. The SCAH and 
the University of Texas Comprehensive Sickle Cell Center have been more involved and 
collaborative. The SCAH provided some of the disease-specific discharge education and 
conducted some post-discharge follow-up calls with certain high-risk patients. Though data was 
not consistently collected and shared, this may have had an impact on the outcomes data. The 
SCAH submitted proposals to embed community health CHWs in the Houston Methodist system 
to support education efforts and to serve as a liaison to thwart unnecessary admissions. The goal 




mitigate SDOH. The CWHs can also assist with patient education, coordinate post-discharge 
follow-up appointments, assist patients with completion of personal health records, and connect 
patients to support groups to strengthen the community network.   
The University of Texas Comprehensive Sickle Cell Center has participated in joint 
operating committee meetings and are exploring ways to better serve patients that access care at 
Houston Methodist facilities and at their Sickle Cell Center. Moreover, we have initiated 
discussions with Texas Children’s Hospital regarding establishing a partnership.  The goal is to 
better bridge patients from pediatric environment to adulthood including navigation of the 
complex adult healthcare system. 
Additionally, State Representative Jarvis Johnson, and United States Congresswoman 
Sheila Jackson-Lee have expressed and shown support of our efforts through the Sickle Cell 
Association of Houston. Representative Johnson and Congresswoman Jackson-Lee expressed 
interest in partnering on drafting and introducing bills to improve funding, access, and care 
practices for patients with SCD.  Patients with SCD have also expressed support and shown 
excitement of such efforts via social media platforms.   
Sustainability Plan 
 The Executive Vice-President and Chief Innovation Officer asked the Chief Nursing 
Officer, Magnet Coordinator, and an Associate Chief Medical Officer (ACMO) to prioritize this 
project to include resource support for spread.  Furthermore, the ACMO participated in meetings 
with the Chief Executive Officer of the SCAH, University of Texas Comprehensive Sickle Cell 
Center leadership, and a state representative.  The purpose of the meetings was to partner with 




 Although weekly distribution and review of process measure data was intended, 
competing priorities and other obligations prevented this cadence. Instead, process measures data 
was distributed bi-weekly.  Leaders shared this data with their respective teams during huddles 
and department meetings and requested feedback.  Feedback included the need for earlier and 
more frequent discharge education and identification and mitigation of social determinants of 
health (SDOH).  The team also suggested direct access to scheduling for case managers and 
creation of a hard stop in the electronic medical record that requires schedulers to enter key 
elements (date, time, location, and provider) in the appointment section of the patient after visit 
summary.  Some of this feedback was incorporated into the project design.    
 Case management and social work leaders, unit directors, quality leaders, and others 
began planning implementation of the last two interventions and discussed a rollout plan for the 
next Houston Methodist facility. Additionally, preliminary discussions regarding sharing and 
distribution of findings at the local, state, and national level started. Unfortunately, the COVID-
19 pandemic halted further implementation and spread. 
Key Lessons Learned 
There were several key lessons learned. To successfully support comprehensive disease 
management for patients with SCD, community partnership is essential. The SCAH played a 
significant role in education and coordination of care both of which were vital to successful 
patient outcomes. The SCAH’s extensive knowledge of SCD, personal experience of living with 
SCD, and familiarity of caring for people with SCD helped to foster trust and inspire altruism. 
The SCAH team helped engender a spirit of connectedness and heighten compassion exhibited 
by the team. This action aligned well with Houston Methodist’s ICARE values of integrity, 




During the implementation phase, we signed a Business Associate Agreement (BAA) 
with the SCAH to support implementation of the four interventions. The BAA did not contain a 
fee structure for reimbursement of services rendered. Thus, support provided by the SCAH 
during this time was complimentary. The SCAH agreed to these terms as a good faith measure to 
show its value and impact on sickle cell outcomes. Complementary support was not intended to 
continue indefinitely; however, the terms of such support including the timeline were not 
included in the signed BAA. A revised BAA, which included the fee structure for services, was 
later submitted to the Houston Methodist Hospital Chief Financial Officer and the Director of 
Community Benefits for review.  Unfortunately, it was not approved. Though the results of the 
project were positive, the inability to come to an agreement on reimbursement of services led to 
a mutual decision by HMH and the SCAH to dissolve the BAA.  A valuable lesson on contract 
negotiation, fee structures, and reimbursement was learned. 
Establishing a mechanism for direct and real-time communication with federally-
qualified health centers, infusion centers, and other care sites would be helpful. This would aid 
timely scheduling of follow-up appointments, ideally within one week of discharge. Establishing 
a process for automatic social work consults based on provider and nursing assessment and 
identification of social determinations of health may also be useful. Reengineering the 
flowsheets for documentation of patient teaching is another key lesson for improvement. It is 
suggested that HMH refine the flowsheets to support ease of use and incorporate teach-back.  
Another lesson learned was the importance of assessing patient education platforms to 
ensure they are patient-centered. Consideration of reading and comprehension levels and 
incorporation of adult learning strategies are critical. Leveraging smart phones, interactive 




adults including those with SCD. Collaborating with marketing to refine patient education 
materials in a more user-friendly and readable format would have been ideal. Creation and 
utilization of pain passports to guide providers on individualized pain management plans are also 
important. Providing care coordination staff with direct access to schedule post-discharge follow-
up appointments with PCPs or Hematologists would also be ideal.  
Additionally, social media and other forms of information technology have also begun to 
influence the culture of patients and families of patients with SCD.  Parents of patients with SCD 
often use social media to learn more about their child’s disease, to seek and develop a support 
system, and to share concerns or experiences (Vaughn et al., 2011). Young adults often rely on 
social media and other forms of information technology to self-treat symptoms, help with 
isolation and stigma, and to communicate information via message boards, direct messaging, etc. 
to help make decisions about care (Henriques, 2017). Using social media to understand the 
culture and connect with patients and incorporating it into the plan of care may also help ensure 
project success. 
It is important to discuss the impact culture had on this project. African Americans, 
especially those diagnosed with SCD, generally mistrust the healthcare system. Murray (2015) 
noted that mistrust in the healthcare system permeates the African American culture and stems 
from generations of enslavement, discrimination, and abuse. For patients with SCD, perception 
of healthcare provider judgment, generalization, stereotyping, and accusation contribute to 
patient mistrust and subsequent health disparities (Singh et al., 2016). The resulting fear from 
these negative experiences have contributed to a reluctance to trust healthcare providers which 





Cultural and medical mistrust and racial identity encompass attitudinal variables that 
have been shown to affect satisfaction with care in African Americans and inhibit Caucasian 
American providers from establishing care relationships (Benkert et al., 2009). Furthermore, 
provider biases and negative attitudes (Singh et al., 2016) complicate and strain relationships. 
Mistrust is sometimes precipitated by an action or lack of action.  In healthcare, this may have 
severe implications and contribute to misperceptions, decreased patient compliance, lower 
patient satisfaction, lack of quality care, and poor outcomes (Benkert et al., 2009). 
Developing trust is a skill and an art. It requires creating a space where patients feel safe, 
supported, valued, and heard. This space should be devoid of judgment, free of shame, and 
absent of guilt. This is particularly true for patients with SCD as mistrust is high, and satisfaction 
is low.  To build trust, patients with SCD must believe that nurses are trustworthy. Patients must 
feel confident that they will be respected and accepted for who they are and what they believe. 
Dignity and compassion must be maintained, and advocacy upheld. Consistency of displaying 
integrity, honesty, and fidelity during nurse-patient interactions may positively contribute to 
sustaining trust, reducing health disparities, and improving outcomes. 
Incorporating self-assessment and diversity assessment tools into practice or scheduling 
periodic diversity training for all providers and staff is worth consideration. Diversity and 
inclusion training may improve the perception of patients with SCD.  Recruiting and embedding 
Sickle Cell Advocates or Champions throughout the hospital is recommended. Trust is 
fundamental to the relationship between the patient to nurse, patient to provider, etc.; thus, HMH 
should invest time, money, and resources to create a culture of trust and ensure that trust is 






 Implementation of care coordination interventions to reduce the 30-day hospital 
readmission rate for patients with SCD is strongly recommended.  Great success was observed 
by implementing two evidence-based care coordination interventions; thus, the recommendation 
is implementation of at least two interventions to achieve success. Partnering with community 
networks to establish a comprehensive plan is also advised. Assessment and mitigation of SDOH 
would also be ideal. Community networks may have resources and other support necessary to 
manage SDOH and reduce risk factors of patients with SCD. Comprehensive training on SCD 
management is important.  Collaborating with Hematologists and leveraging evidence-based 
SCD toolkits should be part of a hospital’s SCD management protocol. Finally, awareness of 
institutional and cultural bias, diversity and inclusion training, and recruitment of SCD 









Chapter 6: DNP Practice-Scholar Role Actualization 
Role Impact 
 At Houston Methodist, leading medicine is not just a tagline, it is what the organization 
strives to do. Leading medicine can only be achieved by commitment to implementation of 
evidence-based practice and innovation from the providers, nurses, leaders, and all members of 
the interdisciplinary team. The DNP Practice Scholar plays a pivotal role in cultivating a spirit of 
inquiry and creating a culture of evidence-based practice.  The DNP role is not as evolved and is 
underutilized in current state.  There is great opportunity to better leverage this role to transform 
policies and standard operating procedures (SOPs) and lead quality improvement and evidence-
based projects that ultimately enhance patient outcomes and satisfaction. 
 As a DNP Practice Scholar, my plan to diffuse EBP within the organization has begun by 
educating leaders at all levels on EBP, the role of the DNP, and how DNP and PhD leaders can 
collaborate to improve patient care. Education also included:  Review of the EBP process; how 
to conduct a systematic literature search; creation and utility of evidence and synthesis tables and 
Gantt Charts; identification and implementation of evidence-based interventions; and review of 
quality improvement tools including the PDSA cycle and quality charts. Education was an 
important first step because it served as the catalyst to change. I also initiated discussions with 
the Chief Nursing Officer and members of the Magnet Council on creating a culture of EBP, 
hardwiring EBP Standard Operating Procedures (SOPs), and increasing EBP Champions 
throughout the hospital.    
 My strategy to continue diffusing EBP within the organization consists of: (a) working 
with executive leadership on promoting the DNP role, (b) hiring DNP leaders, (c) infusing EBP 




Magnet leadership and nursing quality on recruiting EBP Champions, (f) rewriting policies and 
procedures to include EBP expectations. (g) expanding our EBP Council to include other 
interprofessional roles, (h) partnering with Human Resources to refine role-based clinical ladders 
to include EBP expectations, and (i) implementing a monthly DNP Support Group to support 
DNPs throughout their journey at Houston Methodist. I would also like to work closely with 
midlevel leaders on how to hardwire EBP processes in their service areas to improve patient 
outcomes. In addition, partnering with our Patient & Family Experience team to ensure patient 
advocates are involved in our EBP initiatives is of interest. 
 Houston Methodist Hospital is a Magnet-designated hospital. Nurses at Magnet-
designated hospitals have higher knowledge, stronger perceived EBP cultures, and greater EBP 
mentoring than non-Magnet-designated nurses (Melnyk et al., 2010). EBP has been linked to 
positive nursing and patient outcomes as nurses set the standards for excellence through 
leadership, scientific discovery and dissemination, and implementation of new knowledge 
(American Nurses Credentialing Center, 2020). The DNP educated nurse has unique skills. The 
DNP can contribute to clinical practice, leadership, health policy, implementation and evaluation 
of evidence-based research, and nursing education (Tenhunen et al., 2019).   
 Though a Magnet-designated hospital with organizational recognition of the role of EBP 
in healthcare, leader awareness of EBP is variable, EBP competencies are inconsistently applied, 
and cultural readiness for change is tenuous. In general, mid-level and executive leaders were 
misinformed about the actual role of the DNP and its value. The weakness of this knowledge 
deficit is that these leaders are unable to advocate or articulate the importance of the role and its 
benefits to patients, staff, and the organization. Opportunities remain to continue education about 




Additional opportunities include demonstration of the value of the DNP, implementing a DNP 
recruitment and retention strategy, and increasing organizational DNP utilization. These actions 
may decrease the threats of poor patient outcomes, disinterest in DNP terminal degree 
attainment, and increased turnover post-graduation secondary to lack of organizational support of 
the DNP role. 
  My future goal as a DNP leader is to inspire and encourage a cadre of nurse scholars to 
be change-makers in healthcare. I aspire to take a more active role in healthcare reform by 
empowering and advocating for equitable access to quality care, affordable care, and a more 
diverse and inclusive healthcare workforce especially at the executive level. I want to educate 
policy-makers about SDOH.  I would also like to reform broken and antiquated systems that 
disenfranchise people of color and predispose minorities to poor quality of life and high 
morbidity and mortality. I also want to serve as a mentor to healthcare leaders at all levels.  
Finally, I hope to partner with high schools and community networks to educate African 
American males on health promotion and disease prevention while simultaneously exposing and 
inspiring them to enter the field of nursing. 
Summary 
 The DNP program has been challenging and rewarding. The rigor of this program was 
unlike any other I have undergone. This experience has ignited my passion, tested my patience, 
and amplified my persistence. Throughout this journey, I have leveraged and leaned into my 
strengths. In reviewing my top five Strengths Finders 2.0 Strengths, two of the top five strengths 
fall into the Relationship Building domain (Includer and Positivity), two falls into the Influencing 
domain (Winning Others Over—WOO and Communication), and one falls into the Executing 




domain. I have learned that I am more people-focused and I thrive off interacting and 
collaborating with others. Utilization of my top five strengths have helped me feel more engaged, 
productive, and connected. I also feel less stressed and more confident. This journey has taught 
me to pay more attention to other’s strengths as well and to proactively look for ways to improve 
communication and collaboration.   
  This experience has also helped improve my emotional intelligence. Early in this journey, 
I learned that my collective management in personal competence (self-awareness and self-
management) is strong. I was also strong in one aspect of social competence (social awareness); 
however, there was opportunity to strengthen the other aspect of social competence (relationship 
management) (Bradberry & Greaves, 2009). Though I could accurately pick up on the emotions 
of others and sense what they were thinking and feeling, I was not as good at using my 
awareness to manage interactions successfully. To build my relationship management and thus 
improve my overall emotional intelligence, I made a conscious effort to explain my decisions, 
address difficult situations timely and consistently, and to be more open and curious. I am now 
aware of the need to be vulnerable and, when appropriate, share more of myself with others.   
 This journey has also strengthened my global understanding of leadership and the impact 
that it has on individuals, groups, and the health care system. I have become a more well-
rounded leader and have grown in two areas of leadership that I have struggled with in the past:  
Organizational savviness and financial/business acumen. I am delighted to say that I have done 
so while maintaining work-life balance and actively engaging in self-care. The difficult road to 
obtain the DNP could not have been achieved without prayer, passion, and persistence.  I am 
proud of this accomplishment and very much looking forward to positively contributing to 
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Appendix G: Levels and Types of Evidence 
 
Level of Evidence 1 2 3 4 5 6 7 8 9 10 11 Synthesis 
Level 1: Systematic 
Review or Meta-
Analysis 
           0 of 11 
Level II:  Randomized 
Control Trials 
X           1 of 11 
Level III: Control 
Trials without 
Randomization 
           0 of 11 
Level IV: Case Control 
or Cohort Study 
 X X X X X X X 
 
  7 of 11 
Level V: Systematic 
Review of Qualitative 
or Descriptive Study 
           0 of 11 
Level VI: Qualitative 




        X X X 3 of 11 
Level VII: Expert 
Opinion or Consensus 
           0 of 11 
1 = Bronstein, L.R., et al. (2015); 2 = Gao, W., et al. (2018); 3 = Dangi-Garimella, S. (2015); 4 = Limenis (2017); 5 = Harrison et al. (2014); 6 = Lanzkron, S. 
et al. (2015); 7 = Koch, K. L., et al. (2013); 8 = Leschke, J., et al. (2012); 9 = Manwani, D., et al. (2014); 10 = Pashankar, F.D., et al. (2018); 11 = Onimoe, 






Appendix H: Synthesis Table: Interventions 
 
 
Interventions 1 2 3 4 5 6 7 8 9 10 11 Synthesis 
Home Visit X X          2 of 11 
Post Discharge 
Phone Calls 




 X X       X X 4 of 11 
Inpatient Care 
Planning 
        X   1 of 11 
Schedule Follow-
up visits before 
discharge 




  X         1 of 11 
Self-management 
strategies 
  X  
 
       1 of 11 
Sickle Cell 
Outpatient Infusion 
Center / Clinic 
     X X     2 of 11 
Prescribe 
Hydroxyurea 
         X X 2 of 11 
1 = Bronstein, L.R., et al. (2015); 2 = Gao, W., et al. (2018); 3 = Dangi-Garimella, S. (2015); 4 = Limenis (2017); 5 = Harrison et al. (2014); 6 = Lanzkron, S. 
et al. (2015); 7 = Koch, K. L., et al. (2013); 8 = Leschke, J., et al. (2012); 9 = Manwani, D., et al. (2014); 10 = Pashankar, F.D., et al. (2018); 11 = Onimoe, 







Appendix I: Synthesis Table: Outcomes 
 




















Outcomes             
Self-Management            1 of 11 
30-day Readmission 
Rate 
   -        10 of 11 
14-day Readmission 
Rate 
           1 of 11 
Patient satisfaction / 
engagement 
           2 of 11 
Health Literacy            1 of 11 
Number of Infusion 
Visits 
           1 of 11 
ED visits            1 of 11 
Admissions / Acute Care 
Utilization 
           3 of 11 
Length of Stay (LOS)            2 of 11 
High Utilizers            1 of 11 
1 = Bronstein, L.R., et al. (2015); 2 = Gao, W., et al. (2018); 3 = Dangi-Garimella, S. (2015); 4 = Limenis (2017); 5 = Harrison et al. (2014); 6 = Lanzkron, S. et al. (2015); 7 = 
Koch, K. L., et al. (2013); 8 = Leschke, J., et al. (2012); 9 = Manwani, D., et al. (2014); 10 = Pashankar, F.D., et al. (2018); 11 = Onimoe, G.I., et al. (2016). 
HV=Home Visits; PDCC=Post-discharge calls; DCE=Discharge Education; FUA=Follow-Up Appointments; YATC = Youth Adult Transition Center; SMS =self-management 
system; SCIC = Sickle Cell Infusion Center; ICP = Inpatient Care Plan; HYDR = Hydroxyurea  










Year No. of 
Participants 
Mean Age Study 
Design 
Intervention Major finding that addresses PICOT 
2 Gao, W., et 
al. 
2018 149,748 - PCS HV 
DCE 
FUA 









DCE, FUA, YATC, and SMS reduce RR. 
9 Manwani, 
D., et al. 
2014 - - QIP ICP 
FUA 
ICP and FUA reduce LOS and RR. 
10 Pashankar, 
F.D., et al. 




DCE, PDCC, FUA, HYDR reduce LOS, acute admissions, and 
RR. 
11 Onimoe, 
G.I., et al. 




DCE, FUA, PDCC, and HYDR reduce RR. 
CC=Care Coordination; DC=Discharge; DCE=Discharge Education; DCI=Discharge Instructions; FUA=Follow-up Appointments; HV = Home Visits;  ICP = 
Inpatient Care Plan; LOS = Length of Stay; MM=Medication Management; PCS=Prospective Cohort Study; QIP=Quality Improvement Project; PDCC=Post-
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Appendix M: Logic Model 
 
Program Name and Student Name: UT Tyler DNP Program, Leadership Track 
                                                             Naph’tali Edge 
 
Program Goal:  Reduce unnecessary, avoidable 30-day hospital readmissions of patients with a primary diagnosis of sickle cell 
disease (SCD) by 20% over the course of 3 months. 
 
Resources/Inputs 
 Necessities List Wish List 
Human Resources 
1. Nurse Educator 
Provide 1 hour of training on SCD discharge 
teaching to nursing staff.  Estimated number 
of staff requiring education will be 120 RNs.  
This will include staff on all shifts (i.e. day, 
night, and weekend). Estimated time 
commitment needed for Nurse Educator will 
be 15 hours pre-implementation.  Post 
implementation estimates include a total of 5 
hours of Nurse Educator time for re-education 
to staff. Estimate approximately 20% or 12 
staff RNs may require re-education. 





1. Dedicated RN or discharge nurse for the sickle 
cell population 
2. Community Health Worker support to connect 
with patients prior to discharge, participate in 
education with RN, and continue education 
post-discharge (including completion of a 
personal health record. 
3. Unit Secretary support to schedule all post-





Appendix M: Logic Model continued 
 
 
Provide 1-hour training on how to schedule 
follow-up appointments to Care Coordination 
staff.  Estimated number of staff requiring 
training will be 100.  Anticipate one-time 
training for each staff member with training to 
occur pre-implementation. This will include 
staff on day shift.  Do not anticipate need for 
Nurse Educator to re-educate staff on the 
scheduling process. 
 
Care Coordination post-discharge follow-up 
calls.  Estimated time for each call will be one 
hour each week for a total of four weeks. 
 
Community Health Worker post-discharge 
home visits.  Estimate two one-hour phone 









Appendix M: Logic Model Continued 
 
Office Supplies 
1. Office paper and color ink cartridges 
Anticipate needing approximately 25 reems of 
paper and 10 color ink cartridges to provide 
discharge literature for approximately 150 
SCD inpatient encounters (60 for first month, 
50 for second month, 40 for third month).  
2. Discharge Binders 




1. iPads to distribute to patients with SCD for 
alternative discharge teaching/learning (i.e. 
computer-based, video game, interactive, 
etc.). 
2. PHR costs absorbed by community partner 
(Sickle Cell Association of Houston). 
Organization Resources 
1. Dedicated call line for staff to call to schedule 
post-discharge follow-up appointments. 
2. Teach back module uploaded in Learning 
Management System (LMS). This will be the 
learning module utilized by the Nurse 
Educator for training purposes.  Will also use 
to track compliance of teach back as a process 
measure.  
1. Direct access to PCP and/or Hematology 
provider schedules to enter appointments 








Appendix M: Logic Model continued 
 
OUTPUTS OUTCOMES 
Activities Audience(s) Short-Term Mid-Term Long-Term 
1-hour training sessions on care of the 
patient with SCD.  Training to focus 
on management of sickle cell disease 
including self-management strategies, 
red flags to watch for, medication 
management, alternative health 
strategies, community resources and 
connections, follow-up care, etc. 
 
 
Collaborative meetings with team 
including outpatient team to discuss 
care transitions and care coordination 
across the continuum.  Team building 




1-hour training sessions on scheduling 
follow-up appointments and 
conducting post-discharge phone 
calls.  Training should include 
collaboration with patients and 
families to assess most date/time of 
appointment most convenient to them 
and assessing for and arranging 
































Increased unit RN staff understanding of SCD 
management and patient self-management education 
as evidenced by improved post-test scores 







Completion and distribution of employee profiles for 
at least 90% of team members to encourage getting 




Improvement of scheduling process as evidenced by 
increased number of follow-up appointments 
scheduled prior to patient discharge within 1 month 
of project implementation. 
Consistency in conducting weekly post-discharge 
phone calls to support transitions of care. 
Increased patient compliance of 
self-management strategies as 
evidenced by completion of 
personal health record and 
improved patient satisfaction on 
discharge-related and transition of 
care questions on patient 
satisfaction survey within the first 
90 days of project implementation. 
 
Increased patient satisfaction with 
staff communication and 
collaboration as evidenced by 
improvement in patient satisfaction 
survey within the first 90 days of 
project implementation. 
 
Improvement in scheduling process 
as evidenced by increased number 
and percentage of patients that 
keep/attend follow-up appointments 
within first 90 days of project 
implementation. 
Compliance with conducting 
weekly calls as evidenced by 
increased patient understanding of 
self-management, red flags to 
watch for, and transitions of care. 
Increased staff satisfaction as 
evidenced by improvement 
employee engagement scores 











Increased staff satisfaction as 
evidenced by improvement 
employee engagement scores 






Increased engagement with 
appointment availability via 
patient satisfaction survey within 6 















• Case Managers 
• Social Workers 
• Schedulers 
• Community Partners 
Process Indicators 
 
1. Number of inpatients discharged with SCD diagnosis that receives pre-discharge disease-specific discharge teaching / total number of 
patients discharged with SCD diagnosis X 100. 
Goal:  Threshold >/= 90% compliance       Target >/= 95% compliance 
 
2. Number of inpatients discharged with SCD diagnosis with post-discharge follow-up appointment scheduled prior to discharge / total 
number of patients discharged with SCD diagnosis X 100.  
Goal:  Threshold >/= 90% compliance       Target >/= 95% compliance 
 
3. Number of weekly post-discharge phone calls divided by the total number of expected calls per patient (four calls per patient). 
Goal:  Threshold >/= 90% compliance        Target >/= 95% compliance 
 
 
4. Number of post-discharge home visits completed divided by the total number of expected home visits 
 
Goal:   Threshold >/= 90% compliance          Target >/= 95% compliance 
 
 






Appendix M: Logic Model continued 
 
Environmental/Setting  
Environmental setting will be an inpatient acute care setting on the medical surgical units.  
 
Outcome indicator will include: 
• Readmission Rate 
Times 
• Goal is implementation in Fall/Winter months as evidence suggests that readmissions of patients 








• Executive, Senior, and Mid-level leaders 
• Sickle cell champions 
• Patient/Family Advisors 
• Sickle Cell Scholars and Practice Champions 
• Sickle Cell Association of Houston 
• UT Comprehensive Sickle Cell Center 
 
• Engagement of State Senators and US Representatives would be ideal. 
Assumptions 
• Readmission Rate is too high and can be decreased. 
• Patients with SCDs want to improve health and avoid unnecessary readmissions. 
• Care coordination is not currently occurring. 
• Social Worker is equivalent of Case Manager and perform the same functions. 
• Schedulers will be available to assist with scheduling follow-up appointments. 
• Nurses do not provide appropriate/effective training. 
• Nursing staff do not understand SCD disease management. 
• Number of patients with SCD won’t change drastically. 
 










  Barriers Needs Frequency Facilitator 
Healthcare providers and IDT knowledge 
deficit regarding SCD 
Staff education and awareness regarding 
SCD management. 
One time—Pre-implementation training to 
medical staff (ED Providers and 
Hospitalists), nursing staff, and case 
management and social work staff. 
Nurse Education Specialist 
Pathway Adherence Provider education on the integrated, 
electronic SCD care management 
pathway. 
One time—Pre-implementation training to 
medical staff (ED Providers and 
Hospitalists). 
Associate Chief Quality Officer 
Team Judgment Provider and staff education on providing 
culturally sensitive, nonjudgmental care. 
One-time—Pre-implementation training to 
medical staff (ED Providers and 
Hospitalists). 
Associate Chief Quality Officer  
 
Sickle Cell Association of Houston 
 
Patient Lack of Trust Trust building assessments with patients 
and providers. 
Completion of Cultural Mistrust Inventory 
(CMI), Trust in Provider Scale (TPS), 
Black Racial Identity Attitude Scale 
(BRIAS), and/or the Group Based Medical 
Mistrust Scale (GBMMS) 
Nurse Education Specialist 
Staff Resources  Nurses to complete the patient education. 
Case Management Staff to schedule the 
post-discharge follow-up appointment prior 
to discharge and conduct the post-
discharge phone calls.  Community Health 
Worker (CHW) will conduct the home 
visits. 
Daily education with each patient during 
the inpatient stay. One-time scheduling of 
follow-up appointment prior to discharge. 
Weekly post-discharge follow-up phone 
calls. 
Two post-discharge home visits. 
Unit Registered Nurses 
Care Coordinators 
Community Health Worker  
Time Management Team education on time management of 
interventions. 
Weekly reinforcement and education. Director, Case Management and Social 
Work. 
Competing Priorities Team education on prioritization of 
interventions. 
Weekly reinforcement and education. Director, Case Management and Social 
Work 
Inconsistency and. lack of commitment Leadership expectations, oversight, and 
accountability. 
Weekly audits and team meetings. Associate Chief Quality Officer, Case 
Management Medical Director, Nursing 
leadership, and Case Management 
leadership team. 
IT Support Distribution of list of patients with SCD.   
Distribution of report with intervention 
compliance. 
Daily list.    
Weekly report. 
 
















































Appendix R: Process Measures Results 
 
SCD-specific education 
Threshold >/= 90% 
Target >/= 95% 
 
 
Baseline data:  ~51%  
Post-discharge follow-up 
appointments 
Threshold >/= 90% 
Target >/= 95% 
 
Baseline data: ~15%  





Number of encounters with 
post-discharge follow-up 
appointment scheduled prior 
to discharge 
132 
Total number of encounters 178 
 
Total number of encounters 178 




Reasons appointments not scheduled 
Patient Refusal or request for self-schedule 17 
Incomplete appointments 14 
Unplanned discharges 6 
Staff omissions (forgot to schedule) 5 





Appendix S:  Outcome Measures Results 
 











Emergency 134 109 243 18.7% 
Inpatient 208 178 386 14.4% 
Observation 68 52 120 23.5% 












Inpatients 208 178 30   
30-day readmissions 95 64 31  
 




















of stay (ALOS) 
 
Inpatient 208 7.7 178 6.8 11.7% 
 
Observation 68 1.0 52 1.0 0.0% 
 
 
